Severe Asthma in School-Age Children: An Updated Appraisal on Biological Options and Challenges in This Age Group
This review examines the growing role of biological therapies in managing severe asthma in children aged 6–11 years. Severe asthma, characterized by persistent symptoms and frequent exacerbations, presents significant challenges in pediatric care. Biologic treatments, including mepolizumab, omalizum...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2025-01-01
|
| Col·lecció: | Children |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/2227-9067/12/2/167 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|